Navigation Links
Headway in identification of allergens of contact dermatitis

Contact dermatitis is an allergic reaction caused to many human beings. A new Mayo Clinic study reveals the most common causes of // allergic contact dermatitis. The exact definition of contact dermatitis is that it is a skin inflammation resulting in swollen, reddened and itchy skin due to direct contact with an allergen.

The ten allergens identified by the mayo study are as follows:-

? Nickel (nickel sulfate hexahydrate

? Gold (gold sodium thiosulfate)

? Balsam of Peru (myroxylon pereirae)

? Thimerosal

? Neomycin sulfate

? Fragrance mix

? Formaldehyde

? Cobalt chloride

? Bacitracin

? Quaternium 15

The study also confirmed that patch testing with a standard contact dermatitis series of substances is useful for identifying common contact allergens. The study confirmed previous findings by the North American Contact Dermatitis Group.

Contact dermatitis testing results from 3,854 patients over a five-year period between Jan. 1, 2001 and Dec. 31, 2005 were studied for the study. The patients were tested with an average of 69 allergens. Of these patients, 2,663 (69 percent) had at least one positive reaction, and 1,933 (50 percent) had two or more positive reactions.

Contact dermatitis is common among all age groups and can cause minor annoyance to more severe handicaps, according to Mark Davis, M.D., Mayo Clinic dermatologist and lead study researcher. "Patients with contact dermatitis can get a very itchy rash from head to toe, or in a confined area," he says. "If it's on the hands and feet it can be disabling, and patients at times can't do their jobs."
'"/>




Page: 1

Related medicine news :

1. Making Headway Against Hepatitis C
2. Researchers Make Headway in Treatment of Diabetic Retinopathy
3. Early identification of autism possible
4. Computer aided cancer identification in young women
5. Evoprinter, a multigenomic comparative tool for rapid identification of functionally important DNA
6. MRI can predict risk of cardiac arrhythmia by identification of scar tissue
7. Childhood asthma may be triggered by cockroach allergens
8. Reduce eye infection through new-age contact lenses
9. New contact lens materials
10. Newborns Know how to make eye contact
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... planning services from offices headquartered in Jefferson County, is announcing the launch of ... in Birmingham. , The number of homeless women and children in Birmingham has ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Markets has announced the addition of the "Endodontic Supplies - Global Strategic ... , ... for Endodontic Supplies in US$ Thousand. The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year historic analysis is ...
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: